Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | -14.91% |
| 10 | Organogenesis Holdings | 329.72 Mn | 237.62 Mn | 11.46 Mn | 8,663.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,663.01% |
| Dec 31, 2025 | -6,620.74% |
| Sep 30, 2025 | 2.04% |
| Jun 30, 2025 | 50.31% |
| Mar 31, 2025 | -311.28% |
| Dec 31, 2024 | -792.07% |
| Sep 30, 2024 | 1,316.20% |
| Jun 30, 2024 | -3,025.23% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | 77.86% |
| Sep 30, 2023 | 390.95% |
| Jun 30, 2023 | -13.14% |
| Mar 31, 2023 | -685.14% |
| Dec 31, 2022 | -114.38% |
| Sep 30, 2022 | -88.55% |
| Jun 30, 2022 | -31.48% |
| Mar 31, 2022 | -101.07% |
| Dec 31, 2021 | 61.28% |
| Sep 30, 2021 | -98.22% |
| Jun 30, 2021 | 180.70% |